您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:医思健康2024/25年报 - 发现报告

医思健康2024/25年报

2025-07-31港股财报M***
AI智能总结
查看更多
医思健康2024/25年报

Contents 6 Financial Highlights and Five-Year Summary Financial Highlights and Five-Year Summary Notes: 1. 1.EBITDA equals earnings before interests, taxation, depreciation-owned property,plant and equipment and amortisation. EBITDA is not standard measure underHKFRS. The Company’s management believes that EBITDA, as a proxy ofoperating cash flow generated by the Group’s businesses, provide investors withuseful supplementary information to assess the performance of the Group. In addition to EBITDA, we present Adjusted EBITDA as a supplemental non-HKFRS financial measure. We present these financial measures because they are used by our managementto evaluate our financial performance by eliminating the impact of items (i.e.one off and non-recurring items) that we do not consider indicative of theperformance of our business. We also believe that the Adjusted EBITDA provideadditional information to investors and others in understanding and evaluatingour consolidated results of operations in the same manner as they help ourmanagement and in comparing financial results across accounting periods. When assessing our operating and financial performance, readers shouldnot view the Adjusted EBITDA in isolation or as a substitute for our profit forthe period or any other operating performance measure that is calculated inaccordance with HKFRS. In addition, because Adjusted EBITDA may not becalculated in the same manner by all companies, they may not be comparable toother similarly titled measures used by other companies. Financial Highlights and Five-Year Summary The following table sets out the reconciliation of the EBITDA and (loss)/profitbefore tax for the periods indicated: Financial Highlights and Five-Year Summary 2.2.EBITDA Margin equals earnings before interests, taxation, depreciation-ownedproperty, plant and equipment and amortisation over total revenue of the financialyear. 3.Net loss/profit margin equals profit for the year divided by revenue for the sameperiod. EC Healthcare at a Glance MISSION VISION CORE VALUES IntegrityEmpathyCo-OwnershipDisruptive AgilityExcellence Geographical Coverage Total of 164 service points across 591,000 sq ft covering Greater China (as of 31 March 2025)591,000164 One-Stop, Multi-Brand Ecosystem 48 diverse brands: luxury and affordable options catering to a wide range of customers48 Aesthetic Medical, Beautyand Wellness Brands美學醫療、美容及養生品牌11 Lab Testing and Screening檢測及化驗 Chairman’s Statement Dear Shareholders, As we reflect on the past year, I am pleased to share how ECHealthcare has navigated a complex and evolving landscapewith strategic clarity and resilience. The macroeconomicenvironment has presented significant challenges, includingpersistent inflation, shifting consumer behaviors, and intensifyingcompetition in Hong Kong’s healthcare sector. Through swiftand decisive measures during the financial year, we successfullyrationalized our cost structure to achieve substantial recurringannual savings against our baseline operations, significantlystrengthening our financial position for the future. Our approach has been anchored in three strategic pillars: strengtheningour core business, driving operational excellence, and acceleratingdigital transformation. We have developed clear integration plans for ourvarious assets, particularly in dental, health screening & laboratory, andmedical specialty pillars, with systematic consolidation of IT, HR, finance,centralized procurement and customer service functions to be completedin 2026. These initiatives will unleash powerful synergies and drivemeaningful financial improvement across our organization. In our Medical Services segment, we have made meaningful progressin diversifying our revenue streams by deepening partnerships withinsurers and government programs. We are persistently executingour defined consolidation platform strategy to effectively drive growthand diversification of market segments through dedicated businessdevelopment efforts. This is complemented by enhanced operationalefficiency through robust capital and asset management, along withaccelerated digital integration across our brands – a comprehensiveapproach that positions us to return to net profitability within the comingthree years. Chairman’s Statement The Aesthetic, Beauty, and Wellness segment has faced headwindsdue to cautious consumer sentiment, but our strategic acquisitionof a premium regional chain has strengthened our market positionand created synergies across our expanded network. By integratingrenowned brands and investing in cutting-edge technologies, we arereinforcing our leadership in this competitive space while preparing for arecovery in consumer confidence. Our Veterinary Services division has demonstrated resilience, benefitingfrom stable local demand and the growing recognition of our AnimalMedical Academy Hospital as a center of excellence. The recent easingof cross-border pet quarantine rules has further so